Proteomic analysis of extracellular matrix and vesicles

Journal of Proteomics

Volumn 72, Issue 1, 2009, Pages 34-45

  Xiao, Zhen ^a   Blonder, Josip ^a   Zhou, Ming ^a   Veenstra, Timothy D ^a  

^a SAIC FREDERICK INC   (United States)

Author keywords

Exosomes; Extracellular matrix; Extracellular vesicles; Mass spectrometry; Proteomics

Indexed keywords

BIOLOGICAL MARKER; RNA; TUMOR MARKER; VACCINE;

BIOGENESIS; CANCER CELL CULTURE; CELL FUNCTION; CELL STRUCTURE; CONNECTIVE TISSUE; DEVELOPMENTAL BIOLOGY; EUKARYOTIC CELL; EXOSOME; EXTRACELLULAR MATRIX; HUMAN; IMMUNOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEOMICS; REVIEW; RNA TRANSPORT; SECRETORY VESICLE;

ANIMALS; EXOCYTOSIS; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; GLYCOPROTEINS; HUMANS; PROTEOME; SECRETORY VESICLES; TUMOR MARKERS, BIOLOGICAL;

EUKARYOTA;

EID: 60649085328     PISSN: 18743919     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jprot.2008.11.011     Document Type: Review

References (106)

1. Mosher D.F., Sottile J., Wu C., and McDonald J.A. Assembly of extracellular matrix. Curr Opin Cell Biol 4 (1992) 810-818
2. McDonald J.A. Matrix regulation of cell shape and gene expression. Curr Opin Cell Biol 1 (1989) 995-999
3. Adams J.C., and Watt F.M. Regulation of development and differentiation by the extracellular matrix. Development 117 (1993) 1183-1198
4. Streuli C. Extracellular matrix remodelling and cellular differentiation. Curr Opin Cell Biol 11 (1999) 634-640
5. Anderson H.C. Molecular biology of matrix vesicles. Clin Orthop Relat Res (1995) 266-280
6. Schorey J.S., and Bhatnagar S. Exosome function: from tumor immunology to pathogen biology. Traffic 9 (2008) 871-881
7. Pfeffer S.R. Transport-vesicle targeting: tethers before SNAREs. Nat Cell Biol 1 (1999) E17-22
8. von Zastrow M., and Sorkin A. Signaling on the endocytic pathway. Curr Opin Cell Biol 19 (2007) 436-445
9. Raposo G., Marks M.S., and Cutler D.F. Lysosome-related organelles: driving post-Golgi compartments into specialisation. Curr Opin Cell Biol 19 (2007) 394-401
10. Rizo J., and Rosenmund C. Synaptic vesicle fusion. Nat Struct Mol Biol 15 (2008) 665-674
11. Anderson H.C. Matrix vesicles and calcification. Curr Rheumatol Rep 5 (2003) 222-226
12. Anderson H.C. Matrix vesicle calcification. Fed Proc 35 (1976) 104
13. Harding C., Heuser J., and Stahl P. Endocytosis and intracellular processing of transferrin and colloidal gold-transferrin in rat reticulocytes: demonstration of a pathway for receptor shedding. Eur J Cell Biol 35 (1984) 256-263
14. Pan B.T., and Johnstone R.M. Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: selective externalization of the receptor. Cell 33 (1983) 967-978
15. Harding C., Heuser J., and Stahl P. Receptor-mediated endocytosis of transferrin and recycling of the transferrin receptor in rat reticulocytes. J Cell Biol 97 (1983) 329-339
16. Pan B.T., and Johnstone R. Selective externalization of the transferrin receptor by sheep reticulocytes in vitro. Response to ligands and inhibitors of endocytosis. J Biol Chem 259 (1984) 9776-9782
17. Ariztia E.V., Lee C.J., Gogoi R., and Fishman D.A. The tumor microenvironment: key to early detection. Crit Rev Clin Lab Sci 43 (2006) 393-425
18. Chen S.T., Pan T.L., Juan H.F., Chen T.Y., Lin Y.S., and Huang C.M. Breast tumor microenvironment: proteomics highlights the treatments targeting secretome. J Proteome Res 7 (2008) 1379-1387
19. Hale J.E., and Wuthier R.E. The mechanism of matrix vesicle formation. Studies on the composition of chondrocyte microvilli and on the effects of microfilament-perturbing agents on cellular vesiculation. J Biol Chem 262 (1987) 1916-1925
20. Kardos T.B., and Hubbard M.J. Are matrix vesicles apoptotic bodies?. Prog Clin Biol Res 101 (1982) 45-60
21. Xiao Z., Camalier C.E., Nagashima K., Chan K.C., Lucas D.A., de la Cruz M.J., et al. Analysis of the extracellular matrix vesicle proteome in mineralizing osteoblasts. J Cell Physiol 210 (2007) 325-335
22. Ikonen E. Roles of lipid rafts in membrane transport. Curr Opin Cell Biol 13 (2001) 470-477
23. Salaun C., James D.J., and Chamberlain L.H. Lipid rafts and the regulation of exocytosis. Traffic 5 (2004) 255-264
24. de Gassart A., Geminard C., Fevrier B., Raposo G., and Vidal M. Lipid raft-associated protein sorting in exosomes. Blood 102 (2003) 4336-4344
25. Iozzo R.V. Matrix proteoglycans: from molecular design to cellular function. Annu Rev Biochem 67 (1998) 609-652
26. Bernfield M., Gotte M., Park P.W., Reizes O., Fitzgerald M.L., Lincecum J., et al. Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem 68 (1999) 729-777
27. Iozzo R.V. Basement membrane proteoglycans: from cellar to ceiling. Nat Rev Mol Cell Biol 6 (2005) 646-656
28. Iozzo R.V. Heparan sulfate proteoglycans: intricate molecules with intriguing functions. J Clin Invest 108 (2001) 165-167
29. McDonald J.A., and Camenisch T.D. Hyaluronan: genetic insights into the complex biology of a simple polysaccharide. Glycoconj J 19 (2002) 331-339
30. Lee J.Y., and Spicer A.P. Hyaluronan: a multifunctional, megaDalton, stealth molecule. Curr Opin Cell Biol 12 (2000) 581-586
31. Prockop D.J., and Kivirikko K.I. Collagens: molecular biology, diseases, and potentials for therapy. Annu Rev Biochem 64 (1995) 403-434
32. Debelle L., and Tamburro A.M. Elastin: molecular description and function. Int J Biochem Cell Biol 31 (1999) 261-272
33. Yates III J.R., Gilchrist A., Howell K.E., and Bergeron J.J. Proteomics of organelles and large cellular structures. Nat Rev Mol Cell Biol 6 (2005) 702-714
34. Xiao Z., Conrads T.P., Beck G.R., and Veenstra T.D. Analysis of the extracellular matrix and secreted vesicle proteomes by mass spectrometry. Methods Mol Biol 428 (2008) 231-244
35. Kruk P.A., and Auersperg N. A line of rat ovarian surface epithelium provides a continuous source of complex extracellular matrix. In Vitro Cell Dev Biol Anim 30A (1994) 217-225
36. Beach R.L., Burton W.V., Hendricks W.J., and Festoff B.W. Extracellular matrix synthesis by skeletal muscle in culture. Proteins and effect of enzyme degradation. J Biol Chem 257 (1982) 11437-11442
37. Jakubowski J.A., Hatcher N.G., and Sweedler J.V. Online microdialysis-dynamic nanoelectrospray ionization-mass spectrometry for monitoring neuropeptide secretion. J Mass Spectrom 40 (2005) 924-931
38. Shi Y., Elmets C.A., Smith J.W., Liu Y.T., Chen Y.R., Huang C.P., et al. Quantitative proteomes and in vivo secretomes of progressive and regressive UV-induced fibrosarcoma tumor cells: mimicking tumor microenvironment using a dermis-based cell-trapped system linked to tissue chamber. Proteomics 7 (2007) 4589-4600
39. Huang C.M., Ananthaswamy H.N., Barnes S., Ma Y., Kawai M., and Elmets C.A. Mass spectrometric proteomics profiles of in vivo tumor secretomes: capillary ultrafiltration sampling of regressive tumor masses. Proteomics 6 (2006) 6107-6116
40. Huang C.M., Wang C.C., Barnes S., and Elmets C.A. In vivo detection of secreted proteins from wounded skin using capillary ultrafiltration probes and mass spectrometric proteomics. Proteomics 6 (2006) 5805-5814
41. Huang C.M., Wang C.C., Kawai M., Barnes S., and Elmets C.A. In vivo protein sampling using capillary ultrafiltration semi-permeable hollow fiber and protein identification via mass spectrometry-based proteomics. J Chromatogr A 1109 (2006) 144-151
42. Huang C.M., Wang C.C., Kawai M., Barnes S., and Elmets C.A. Surfactant sodium lauryl sulfate enhances skin vaccination: molecular characterization via a novel technique using ultrafiltration capillaries and mass spectrometric proteomics. Mol Cell Proteomics 5 (2006) 523-532
43. Wubbolts R., Leckie R.S., Veenhuizen P.T., Schwarzmann G., Mobius W., Hoernschemeyer J., et al. Proteomic and biochemical analyses of human B cell-derived exosomes. Potential implications for their function and multivesicular body formation. J Biol Chem 278 (2003) 10963-10972
44. Faure J., Lachenal G., Court M., Hirrlinger J., Chatellard-Causse C., Blot B., et al. Exosomes are released by cultured cortical neurones. Mol Cell Neurosci 31 (2006) 642-648
45. Balcerzak M., Malinowska A., Thouverey C., Sekrecka A., Dadlez M., Buchet R., et al. Proteome analysis of matrix vesicles isolated from femurs of chicken embryo. Proteomics 8 (2008) 192-205
46. Rabesandratana H., Toutant J.P., Reggio H., and Vidal M. Decay-accelerating factor (CD55) and membrane inhibitor of reactive lysis (CD59) are released within exosomes during In vitro maturation of reticulocytes. Blood 91 (1998) 2573-2580
47. Rieu S., Geminard C., Rabesandratana H., Sainte-Marie J., and Vidal M. Exosomes released during reticulocyte maturation bind to fibronectin via integrin alpha4beta1. Eur J Biochem 267 (2000) 583-590
48. Yu S., Liu C., Su K., Wang J., Liu Y., Zhang L., et al. Tumor exosomes inhibit differentiation of bone marrow dendritic cells. J Immunol 178 (2007) 6867-6875
49. Zhang H.G., Kim H., Liu C., Yu S., Wang J., Grizzle W.E., et al. Curcumin reverses breast tumor exosomes mediated immune suppression of NK cell tumor cytotoxicity. Biochim Biophys Acta 1773 (2007) 1116-1123
50. Angelucci A., D'Ascenzo S., Festuccia C., Gravina G.L., Bologna M., Dolo V., et al. Vesicle-associated urokinase plasminogen activator promotes invasion in prostate cancer cell lines. Clin Exp Metastasis 18 (2000) 163-170
51. Runz S., Keller S., Rupp C., Stoeck A., Issa Y., Koensgen D., et al. Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM. Gynecol Oncol 107 (2007) 563-571
52. Taylor D.D., and Gercel-Taylor C. Tumour-derived exosomes and their role in cancer-associated T-cell signalling defects. Br J Cancer 92 (2005) 305-311
53. Millimaggi D., Festuccia C., Angelucci A., D'Ascenzo S., Rucci N., Flati S., et al. Osteoblast-conditioned media stimulate membrane vesicle shedding in prostate cancer cells. Int J Oncol 28 (2006) 909-914
54. Dolo V., Pizzurro P., Ginestra A., and Vittorelli M.L. Inhibitory effects of vesicles shed by human breast carcinoma cells on lymphocyte 3H-thymidine incorporation, are neutralised by anti TGF-beta antibodies. J Submicrosc Cytol Pathol 27 (1995) 535-541
55. Zuccato E., Blott E.J., Holt O., Sigismund S., Shaw M., Bossi G., et al. Sorting of Fas ligand to secretory lysosomes is regulated by mono-ubiquitylation and phosphorylation. J Cell Sci 120 (2007) 191-199
56. Kim S.H., Bianco N., Menon R., Lechman E.R., Shufesky W.J., Morelli A.E., et al. Exosomes derived from genetically modified DC expressing FasL are anti-inflammatory and immunosuppressive. Mol Ther 13 (2006) 289-300
57. Ichim T.E., Zhong Z., Kaushal S., Zheng X., Ren X., Hao X., et al. Exosomes as a tumor immune escape mechanism: possible therapeutic implications. J Transl Med 6 (2008) 37
58. Zitvogel L., Regnault A., Lozier A., Wolfers J., Flament C., Tenza D., et al. Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat Med 4 (1998) 594-600
59. Riteau B., Faure F., Menier C., Viel S., Carosella E.D., Amigorena S., et al. Exosomes bearing HLA-G are released by melanoma cells. Hum Immunol 64 (2003) 1064-1072
60. Mears R., Craven R.A., Hanrahan S., Totty N., Upton C., Young S.L., et al. Proteomic analysis of melanoma-derived exosomes by two-dimensional polyacrylamide gel electrophoresis and mass spectrometry. Proteomics 4 (2004) 4019-4031
61. Murayama T., Kataoka H., Koita H., Nabeshima K., and Koono M. Glycocalyceal bodies in a human rectal carcinoma cell line and their interstitial collagenolytic activities. Virchows Arch B Cell Pathol Incl Mol Pathol 60 (1991) 263-270
62. Zucker S., Wieman J.M., Lysik R.M., Wilkie D.P., Ramamurthy N., and Lane B. Metastatic mouse melanoma cells release collagen-gelatin degrading metalloproteinases as components of shed membrane vesicles. Biochim Biophys Acta 924 (1987) 225-237
63. Dolo V., D'Ascenzo S., Violini S., Pompucci L., Festuccia C., Ginestra A., et al. Matrix-degrading proteinases are shed in membrane vesicles by ovarian cancer cells in vivo and in vitro. Clin Exp Metastasis 17 (1999) 131-140
64. Dolo V., Ginestra A., Cassara D., Ghersi G., Nagase H., and Vittorelli M.L. Shed membrane vesicles and selective localization of gelatinases and MMP-9/TIMP-1 complexes. Ann N Y Acad Sci 878 (1999) 497-499
65. Dolo V., Ginestra A., Cassara D., Violini S., Lucania G., Torrisi M.R., et al. Selective localization of matrix metalloproteinase 9, beta1 integrins, and human lymphocyte antigen class I molecules on membrane vesicles shed by 8701-BC breast carcinoma cells. Cancer Res 58 (1998) 4468-4474
66. Dolo V., Ginestra A., Ghersi G., Nagase H., and Vittorelli M.L. Human breast carcinoma cells cultured in the presence of serum shed membrane vesicles rich in gelatinolytic activities. J Submicrosc Cytol Pathol 26 (1994) 173-180
67. Ginestra A., Miceli D., Dolo V., Romano F.M., and Vittorelli M.L. Membrane vesicles in ovarian cancer fluids: a new potential marker. Anticancer Res 19 (1999) 3439-3445
68. Ginestra A., Monea S., Seghezzi G., Dolo V., Nagase H., Mignatti P., et al. Urokinase plasminogen activator and gelatinases are associated with membrane vesicles shed by human HT1080 fibrosarcoma cells. J Biol Chem 272 (1997) 17216-17222
69. Taraboletti G., D'Ascenzo S., Borsotti P., Giavazzi R., Pavan A., and Dolo V. Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells. Am J Pathol 160 (2002) 673-680
70. Graves L.E., Ariztia E.V., Navari J.R., Matzel H.J., Stack M.S., and Fishman D.A. Proinvasive properties of ovarian cancer ascites-derived membrane vesicles. Cancer Res 64 (2004) 7045-7049
71. Taraboletti G., D'Ascenzo S., Giusti I., Marchetti D., Borsotti P., Millimaggi D., et al. Bioavailability of VEGF in tumor-shed vesicles depends on vesicle burst induced by acidic pH. Neoplasia 8 (2006) 96-103
72. Millimaggi D., Mari M., D'Ascenzo S., Carosa E., Jannini E.A., Zucker S., et al. Tumor vesicle-associated CD147 modulates the angiogenic capability of endothelial cells. Neoplasia 9 (2007) 349-357
73. Pisitkun T., Shen R.F., and Knepper M.A. Identification and proteomic profiling of exosomes in human urine. Proc Natl Acad Sci U S A 101 (2004) 13368-13373
74. Zhou H., Yuen P.S., Pisitkun T., Gonzales P.A., Yasuda H., Dear J.W., et al. Collection, storage, preservation, and normalization of human urinary exosomes for biomarker discovery. Kidney Int 69 (2006) 1471-1476
75. Pisitkun T., Johnstone R., and Knepper M.A. Discovery of urinary biomarkers. Mol Cell Proteomics 5 (2006) 1760-1771
76. Hoorn E.J., Pisitkun T., Zietse R., Gross P., Frokiaer J., Wang N.S., et al. Prospects for urinary proteomics: exosomes as a source of urinary biomarkers. Nephrology (Carlton) 10 (2005) 283-290
77. Knepper M.A., and Pisitkun T. Exosomes in urine: who would have thought...?. Kidney Int 72 (2007) 1043-1045
78. Raposo G., Nijman H.W., Stoorvogel W., Liejendekker R., Harding C.V., Melief C.J., et al. B lymphocytes secrete antigen-presenting vesicles. J Exp Med 183 (1996) 1161-1172
79. Escola J.M., Kleijmeer M.J., Stoorvogel W., Griffith J.M., Yoshie O., and Geuze H.J. Selective enrichment of tetraspan proteins on the internal vesicles of multivesicular endosomes and on exosomes secreted by human B-lymphocytes. J Biol Chem 273 (1998) 20121-20127
80. Thery C., Regnault A., Garin J., Wolfers J., Zitvogel L., Ricciardi-Castagnoli P., et al. Molecular characterization of dendritic cell-derived exosomes. Selective accumulation of the heat shock protein hsc73. J Cell Biol 147 (1999) 599-610
81. Peters P.J., Geuze H.J., Van der Donk H.A., Slot J.W., Griffith J.M., Stam N.J., et al. Molecules relevant for T cell-target cell interaction are present in cytolytic granules of human T lymphocytes. Eur J Immunol 19 (1989) 1469-1475
82. Peters P.J., Geuze H.J., van der Donk H.A., and Borst J. A new model for lethal hit delivery by cytotoxic T lymphocytes. Immunol Today 11 (1990) 28-32
83. Peters P.J., Borst J., Oorschot V., Fukuda M., Krahenbuhl O., Tschopp J., et al. Cytotoxic T lymphocyte granules are secretory lysosomes, containing both perforin and granzymes. J Exp Med 173 (1991) 1099-1109
84. Denzer K., van Eijk M., Kleijmeer M.J., Jakobson E., de Groot C., and Geuze H.J. Follicular dendritic cells carry MHC class II-expressing microvesicles at their surface. J Immunol 165 (2000) 1259-1265
85. Denzer K., Kleijmeer M.J., Heijnen H.F., Stoorvogel W., and Geuze H.J. Exosome: from internal vesicle of the multivesicular body to intercellular signaling device. J Cell Sci 113 Pt 19 (2000) 3365-3374
86. Wolfers J., Lozier A., Raposo G., Regnault A., Thery C., Masurier C., et al. Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat Med 7 (2001) 297-303
87. Bard M.P., Hegmans J.P., Hemmes A., Luider T.M., Willemsen R., Severijnen L.A., et al. Proteomic analysis of exosomes isolated from human malignant pleural effusions. Am J Respir Cell Mol Biol 31 (2004) 114-121
88. Chaput N., Schartz N.E., Andre F., Taieb J., Novault S., Bonnaventure P., et al. Exosomes as potent cell-free peptide-based vaccine. II. Exosomes in CpG adjuvants efficiently prime naive Tc1 lymphocytes leading to tumor rejection. J Immunol 172 (2004) 2137-2146
89. Andre F., Chaput N., Schartz N.E., Flament C., Aubert N., Bernard J., et al. Exosomes as potent cell-free peptide-based vaccine. I. Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells. J Immunol 172 (2004) 2126-2136
90. Hao S., Moyana T., and Xiang J. Review: cancer immunotherapy by exosome-based vaccines. Cancer Biother Radiopharm 22 (2007) 692-703
91. Mignot G., Roux S., Thery C., Segura E., and Zitvogel L. Prospects for exosomes in immunotherapy of cancer. J Cell Mol Med 10 (2006) 376-388
92. Delcayre A., and Le Pecq J.B. Exosomes as novel therapeutic nanodevices. Curr Opin Mol Ther 8 (2006) 31-38
93. Delcayre A., Shu H., and Le Pecq J.B. Dendritic cell-derived exosomes in cancer immunotherapy: exploiting nature's antigen delivery pathway. Expert Rev Anticancer Ther 5 (2005) 537-547
94. Chaput N., Taieb J., Andre F., and Zitvogel L. The potential of exosomes in immunotherapy. Expert Opin Biol Ther 5 (2005) 737-747
95. Valadi H., Ekstrom K., Bossios A., Sjostrand M., Lee J.J., and Lotvall J.O. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9 (2007) 654-659
96. Cox H.D., and Thompson C.M. Purification and proteomic analysis of synaptic vesicles. Methods Mol Biol 432 (2008) 259-274
97. Cordeiro J.M., Meireles S.M., Vale M.G., Oliveira C.R., and Goncalves P.P. Ca(2+) regulation of the carrier-mediated gamma-aminobutyric acid release from isolated synaptic plasma membrane vesicles. Neurosci Res 38 (2000) 385-395
98. Goncalves P.P., Meireles S.M., Neves P., and Vale M.G. Distinction between Ca(2+) pump and Ca(2+)/H(+) antiport activities in synaptic vesicles of sheep brain cortex. Neurochem Int 37 (2000) 387-396
99. Ikemoto A., Bole D.G., and Ueda T. Glycolysis and glutamate accumulation into synaptic vesicles. Role of glyceraldehyde phosphate dehydrogenase and 3-phosphoglycerate kinase. J Biol Chem 278 (2003) 5929-5940
100. Coughenour H.D., Spaulding R.S., and Thompson C.M. The synaptic vesicle proteome: a comparative study in membrane protein identification. Proteomics 4 (2004) 3141-3155
101. Huttner W.B., Schiebler W., Greengard P., and De Camilli P. Synapsin I (protein I), a nerve terminal-specific phosphoprotein. III. Its association with synaptic vesicles studied in a highly purified synaptic vesicle preparation. J Cell Biol 96 (1983) 1374-1388
102. Truant R., Atwal R., and Burtnik A. Hypothesis: Huntingtin may function in membrane association and vesicular trafficking. Biochem Cell Biol 84 (2006) 912-917
103. Hook V., Funkelstein L., Lu D., Bark S., Wegrzyn J., and Hwang S.R. Proteases for processing proneuropeptides into peptide neurotransmitters and hormones. Annu Rev Pharmacol Toxicol 48 (2008) 393-423
104. Hook V.Y. Protease pathways in peptide neurotransmission and neurodegenerative diseases. Cell Mol Neurobiol 26 (2006) 449-469
105. Hook V.Y., and Hwang S.R. Novel secretory vesicle serpins, endopin 1 and endopin 2: endogenous protease inhibitors with distinct target protease specificities. Biol Chem 383 (2002) 1067-1074
106. Rutter G.A., Varadi A., Tsuboi T., Parton L., and Ravier M. Insulin secretion in health and disease: genomics, proteomics and single vesicle dynamics. Biochem Soc Trans 34 (2006) 247-250